At a pivotal moment when the cell therapy industry is experiencing a historic leap and breakthrough, the IGC 2025 10th Annual Cell & Derivative R&D and Industrialization Conference will grandly open on October 30-31 at the Guangzhou Langhao Hotel. This conference, leveraging the policy advantages of the Greater Bay Area, features a main venue and four specialized sessions. It will gather over 60 leading experts from top research institutions, executives from leading enterprises such as Huaxi Lvcity, Xiangxue, Baiji, Dabo, Huaxia, Guanhao, Keyi, Beike, Kexing, Lain, Tiankeya, Qianhui, Aierpu, Xidi, Rizhen, Sipu, Ai Yi, and Aishouma, as well as partners from investment firms to jointly explore cutting-edge fields including in vivo immune cell therapy, MSC/iPSC stem cell therapy, exosome therapy, and anti-aging medical aesthetics.